WCM
PFE icon

Winthrop Capital Management’s Pfizer PFE Stock Holding History

Winthrop Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Buy
12,575
+422
+3% +$11.2K 0.09% 101
2025
Q4 		$303K Sell
12,153
-1,833
-13% -$46.2K 0.07% 111
2025
Q3 		$356K Sell
13,986
-1,007
-7% -$24.9K 0.09% 102
2025
Q2 		$363K Sell
14,993
-17,367
-54% -$405K 0.09% 104
2025
Q1 		$820K Sell
32,360
-228
-0.7% -$5.97K 0.23% 76
2024
Q4 		$861K Buy
+32,588
New +$884K 0.23% 79
2024
Q1 		– Sell
-19,302
Closed -$556K – 251
2023
Q4 		$556K Buy
+19,302
New +$583K 0.18% 90

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Winthrop Capital Management's PFE Position: Q1 2026 in Review

Winthrop Capital Management increased its Pfizer (PFE) stake by 3.5% in Q1 2026, buying an estimated $11.2K and bringing the position to 12,575 shares worth $353K. The position accounts for 0.09% of the portfolio, ranked #101.

Winthrop Capital Management first reported a position in PFE in Q4 2023 and has held it in 7 quarters since. The position peaked at $861K in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Winthrop Capital Management held 12,575 shares of Pfizer worth $353K as of Q1 2026.
  • Winthrop Capital Management bought 422 Pfizer shares in Q1 2026, an estimated $11.2K.
  • Pfizer made up 0.09% of Winthrop Capital Management's portfolio in Q1 2026, its #101 holding.
  • Winthrop Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 7 quarters since.
  • Winthrop Capital Management's Pfizer position peaked at $861K in Q4 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.